DocWire News Editors

DocwireNews

Researchers at MIT have been working on developing a new ingestible implant that may help drugs target specific parts of the body. The device, ReMix, utilizes an &ldquo;in-body GPS&rdquo; that aims to help make diagnoses and guide the administration of drugs. The researchers state that their goal is to provide affordable patient care that less invasive and time consuming than previous methods.With much of their recent research being focused on AI and deep learning, ReMix adds to the growing body of innovative medical technology research. The device, being developed with help from clinicians at Massachusetts General Hospital, uses complex algorithms to spot the location of ingestible implants via wireless signals.Dina Katabi, MIT professor, has used these signals to detect subtle movements and vital signs from afar. MIT Computer Science &amp; Artificial Intelligence Laboratory (CSAIL) researchers have found the device to be effective in animal studies, with the device being tracked within a few centimeters. The goal is for the device to be used similarly in humans, revolutionizing drug therapy.In testing the device, researchers implanted a small sensor in the animals and tracked it with a wireless device. Using an algorithm, the researchers then tracked the device, which does not itself release a signal. The sensor simply reflects the signal sent at it by the wireless device.The researchers claim that the challenge lies within the signal bouncing off many different body parts, more so off the skin than the sensor itself. To combat this issue, the researchers have developed a semiconductor that is capable of combining the signals and filtering out the unwanted frequencies.Going forward, the researchers hope to combine these wireless data with other data, such as MRI radiographs, to enhance the systems accuracy. They also plan to do further research to determine how the algorithm can account for discrepancies in patient physiologies.&ldquo;We want a model that&rsquo;s technically feasible, while still complex enough to accurately represent the human body,&rdquo; said Deepak Vasisht, lead author of the paper on MIT&rsquo;s ReMix research. &ldquo;If we want to use this technology on actual cancer patients one day, it will have to come from better modeling a person&rsquo;s physical structure.&rdquo;<blockquote class="twitter-tweet" data-lang="en">
Can wireless signals help w/ cancer treatments? ReMix, a wireless system by <a href="https://twitter.com/MIT_CSAIL?ref_src=twsrc%5Etfw">@MIT_CSAIL</a>&lsquo;s Dina Katabi and <a href="https://twitter.com/MassGeneralNews?ref_src=twsrc%5Etfw">@MassGeneralNews</a>, aims to change how treatments are monitored and administered to patients. <a href="https://t.co/zdLDBIeiGS">https://t.co/zdLDBIeiGS</a> <a href="https://t.co/Z6WKikuew5">https://t.co/Z6WKikuew5</a> <a href="https://twitter.com/hashtag/healthcare?src=hash&amp;ref_src=twsrc%5Etfw">#healthcare</a> <a href="https://twitter.com/hashtag/technology?src=hash&amp;ref_src=twsrc%5Etfw">#technology</a> <a href="https://twitter.com/hashtag/wireless?src=hash&amp;ref_src=twsrc%5Etfw">#wireless</a>
&mdash; MIT CSAIL Alliances (@csail_alliances) <a href="https://twitter.com/csail_alliances/status/1031951279306752001?ref_src=twsrc%5Etfw">August 21, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Source:&nbsp;<a href="https://www.healthcareitnews.com/news/mit-researchers-make-advances-sensor-implants">Healthcare IT News</a>

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Roger Rodby, MD

Joel M. Topf, MD, FACP

Seldin Award Winner Advocates Online Education

NKF Spring Clinical Meetings 2025

Hatem Soliman, MD

The Future of Dendritic Cell Vaccines in HER2+ Breast Cancer: Toward De-Escalation of Chemotherapy

HER2 Breast Cancer

Latest News

MIT Developing Ingestible Sensor Capable of Targeting Drug Administration

Medical Devices

Researchers at MIT have been working on developing a new ingestible implant that may help drugs target specific parts of the body. The device, ReMix, utilizes an “in-body ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe